SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech vs. Shorts -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (134)8/12/1999 11:46:00 PM
From: biowa  Read Replies (1) | Respond to of 427
 
PB,

I do not, nor have I ever worked for Mark Edwards <g>

I also have to point out that several private biotechs have done convert deals, which locks the buyers up until an IPO (and probably a lock-up period). So much for Jim McCamant's "Most importantly, the buyers are not really investors in the company. They don't care about the long-term health of the company or its business; their main goal is to generate short-term profits."

Thanks for the link, you continue to amaze me.

biowa



To: Pseudo Biologist who wrote (134)8/16/1999 2:07:00 PM
From: Biomaven  Read Replies (1) | Respond to of 427
 
Here's a good article from the National Law Journal on the dread toxic convertibles. It's from earlier this year -I originally posted this a while back on the ARIA thread, but the link has since changed.

test01.ljextra.com

(which is a pretty strange-looking url, so hope it works for others).

Peter


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News